In Focus
Myelodysplastic Syndrome (MDS) Market Analysis
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a decade as it is not merely a cancer, indeed, needs their utmost attention towards the curative treatment before the patients succumb to this deadly disease. Fortunately, the beginning of 21st century has seen a lot coming out from the research such as approvals of hypomethylating agents...
